{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:51:16Z","timestamp":1792270276142,"version":"4.4.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1 HL-087246"],"award-info":[{"award-number":["RO1 HL-087246"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s10741-019-09822-0","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T16:03:11Z","timestamp":1563206591000},"page":"355-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacological preconditioning with phosphodiestrase inhibitor: an answer to stem cell survival against ischemic injury through JAK\/STAT signaling"],"prefix":"10.1007","volume":"25","author":[{"given":"Manju","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"issue":"6","key":"9822_CR1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/scd.2004.13.579","volume":"13","author":"GC Parker","year":"2014","unstructured":"Parker GC, Anastassova-Kristeva M, Broxmeyer HE, Dodge WH, Eisenberg LM, Gehling UM, Guenin LM, Huss R, Moldovan NI, Rao M, Srour EF, Yoder MC (2014) Stem cells: shibboleths of development. Stem Cells Dev 13(6):579\u2013584","journal-title":"Stem Cells Dev"},{"issue":"5","key":"9822_CR2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/scd.2005.14.463","volume":"14","author":"GC Parker","year":"2005","unstructured":"Parker GC, Anastassova-Kristeva M, Eisenberg LM, Rao MS, Williams MA, Sanberg PR, English D; Editorial Board of Stem Cells and Development (2005) Stem cells: shibboleths of development, part II: toward a functional definition. Stem Cells Dev 14(5):463\u2013469","journal-title":"Stem Cells Dev"},{"key":"9822_CR3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861\u2013872","journal-title":"Cell"},{"issue":"5858","key":"9822_CR4","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917\u20131920","journal-title":"Science"},{"key":"9822_CR5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/scd.2011.1500","volume":"20","author":"P Di Nardo","year":"2011","unstructured":"Di Nardo P, Parker GC (2011) Stem cell standardization. Stem Cells Dev 20:375\u2013377","journal-title":"Stem Cells Dev"},{"key":"9822_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/01.CIR.99.1.111","volume":"99","author":"A Rivard","year":"1999","unstructured":"Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, Magner M, Asahara T, Isner JM (1999) Age dependent impairment of angiogenesis. Circulation 99:111\u2013120","journal-title":"Circulation"},{"issue":"2","key":"9822_CR7","first-page":"204","volume":"33","author":"EC Perin","year":"2006","unstructured":"Perin EC (2006) Stem cell therapy for cardiovascular disease. Tex Heart Inst J 33(2):204\u2013208","journal-title":"Tex Heart Inst J"},{"key":"9822_CR8","first-page":"1","volume":"65","author":"KD Kochanek","year":"2016","unstructured":"Kochanek KD, Murphy SL, Xu J, Tejada-Vera B (2016) Deaths: final data for 2014. Natl Vital Stat Rep 65:1\u2013122","journal-title":"Natl Vital Stat Rep"},{"issue":"2","key":"9822_CR9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.118.313251","volume":"123","author":"M Wysoczynki","year":"2018","unstructured":"Wysoczynki M, Khan A, Bolli R (2018) New paradigms in cell therapy: repeated dosing, intravenous delivery, immunomodulatory actions, and new cell types. Circ Res 123(2):138\u2013158","journal-title":"Circ Res"},{"key":"9822_CR10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1096\/fj.05-5211com","volume":"20","author":"M Gnecchi","year":"2006","unstructured":"Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ (2006) Evidence supporting paracrine hypothesis for akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20:661\u2013669","journal-title":"FASEB J"},{"key":"9822_CR11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s11606-013-2508-z","volume":"28","author":"SB Puliafico","year":"2013","unstructured":"Puliafico SB, Penn MS, Silver KH (2013) Stem cell therapy for heart disease. J Gen Intern Med 28:1353\u20131363","journal-title":"J Gen Intern Med"},{"key":"9822_CR12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.vph.2005.02.010","volume":"42","author":"RC Kukreja","year":"2005","unstructured":"Kukreja RC, Salloum F, Das A, Ockaili R, Yin C, Bremer YA, Fisher PW, Wittkamp M, Hawkins J, Chou E, Kukreja AK, Wang X, Marwaha VR, Xi L (2005) Pharmacological preconditioning with sildenafil: basic mechanisms and clinical implications. Vasc Pharmacol 42:219\u2013232","journal-title":"Vasc Pharmacol"},{"key":"9822_CR13","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1161\/CIRCULATIONAHA.105.540500","volume":"112","author":"BA Borlaug","year":"2005","unstructured":"Borlaug BA, Melenovsky V, Marhin T, Fitzgerald P, Kass DA (2005) Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans. Circulation 112:2642\u20132649","journal-title":"Circulation"},{"key":"9822_CR14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-12-394309-5.00006-7","volume":"298","author":"T Kalogeris","year":"2012","unstructured":"Kalogeris T, Baines CP, Krenz M, Korthuis RJ (2012) Cell biology of ischemia\/reperfusion injury. Int Rev Cell Mol Biol 298:229\u2013317","journal-title":"Int Rev Cell Mol Biol"},{"issue":"1","key":"9822_CR15","first-page":"113","volume":"7","author":"T Kalogeris","year":"2017","unstructured":"Kalogeris T, Baines CP, Krenz M, Korthuis RJ (2017) Ischemia\/reperfusion. Compr Physiol 7(1):113\u2013170","journal-title":"Compr Physiol"},{"key":"9822_CR16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4330\/wjc.v3.i6.186","volume":"3","author":"MG Perrelli","year":"2011","unstructured":"Perrelli MG, Pagliaro P, Penna C (2011) Ischemia\/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J Cardiol 3:186\u2013200","journal-title":"World J Cardiol"},{"key":"9822_CR17","doi-asserted-by":"crossref","first-page":"e004389","DOI":"10.1161\/CIRCHEARTFAILURE.117.004389","volume":"10","author":"MA Dubert","year":"2017","unstructured":"Dubert MA, Yow E, Dunn G, Marchev S, Barnhart H, Douglas PS, Goldstein S, Sabbah HN (2017) Novel mitochondria targeting peptide in heart failure treatment. Circ Heart Fail 10:e004389","journal-title":"Circ Heart Fail"},{"key":"9822_CR18","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1161\/01.CIR.88.3.1264","volume":"88","author":"MS Marber","year":"1993","unstructured":"Marber MS, Latchman DS, Walker JM, Yellon DM (1993) Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88:1264\u20131272","journal-title":"Circulation"},{"key":"9822_CR19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00795364","volume":"91","author":"R Bolli","year":"1996","unstructured":"Bolli R (1996) The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview. Basic Res Cardiol 91:57\u201363","journal-title":"Basic Res Cardiol"},{"key":"9822_CR20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/jmcc.1994.1039","volume":"26","author":"A Tsuchida","year":"1994","unstructured":"Tsuchida A, Thompson R, Olsson RA, Downey JM (1994) The anti-infarct effect of an adenosine A1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart. J Mol Cell Cardiol 26:303\u2013311","journal-title":"J Mol Cell Cardiol"},{"key":"9822_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0022-2828(03)00076-2","volume":"35","author":"YT Xuan","year":"2003","unstructured":"Xuan YT, Guo Y, Zhu Y, Han H, Langenbach R, Dawn B, Bolli R (2003) Mechanism of cyclooxygenase-2upregulation in late preconditioning. J Mol Cell Cardiol 35:525\u2013537","journal-title":"J Mol Cell Cardiol"},{"key":"9822_CR22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjp.0707409","volume":"152","author":"DS Burley","year":"2007","unstructured":"Burley DS, Ferdinandy P, Baxter GF (2007) Cyclic GMP and protein kinase-G in myocardial ischemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol 152:855\u2013869","journal-title":"Br J Pharmacol"},{"key":"9822_CR23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cardiores.2005.01.007","volume":"66","author":"Y Abdallah","year":"2005","unstructured":"Abdallah Y, Gkatzoflia A, Pieper H, Zoga E, Walther S, Kasseckert S, Sch\u00e4fer M, Schl\u00fcter KD, Piper HM, Sch\u00e4fer C (2005) Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury. Cardiovasc Res 66:123\u2013131","journal-title":"Cardiovasc Res"},{"key":"9822_CR24","doi-asserted-by":"crossref","first-page":"ii44","DOI":"10.1093\/bja\/aew267","volume":"117","author":"Z Xia","year":"2016","unstructured":"Xia Z, Li H, Irwin MG (2016) Myocardialischemia-reperfusion injury: the challenge of translating ischaemic and anesthetic protection from animal models to humans. Br J Anaesth 117:ii44\u2013ii62","journal-title":"Br J Anaesth"},{"key":"9822_CR25","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1089\/scd.2014.0288","volume":"24","author":"S Kumar","year":"2015","unstructured":"Kumar S, Ashraf M (2015) Tadalafil, a phosphodiestrase inhibitor protects stem cells over longer period against hypoxia\/reoxygenation injury through STAT3\/PKG-I signaling. Stem Cells Dev 24:1332\u20131341","journal-title":"Stem Cells Dev"},{"key":"9822_CR26","doi-asserted-by":"crossref","first-page":"H2272","DOI":"10.1152\/ajpheart.00654.2010","volume":"300","author":"VQ Chau","year":"2011","unstructured":"Chau VQ, Salloum FN, Hoke NN, Abbate A, Kukreja RC (2011) Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA\/Rho-kinase pathway. Am J Physiol Heart Circ Physiol 300:H2272\u2013H2279","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9822_CR27","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/ATVBAHA.109.201327","volume":"30","author":"M Sahara","year":"2010","unstructured":"Sahara M, Sata M, Morita T, Nakajima T, Hirata Y, Nagai R (2010) A phosphodiestrase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1\/vascular endothelial growth factor pathway. Arterioscler Thromb Vasc Biol 30:1315\u20131324","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"9822_CR28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","volume":"122","author":"EJ Tsai","year":"2009","unstructured":"Tsai EJ, Kass DA (2009) Cyclic GMP signaling in cardiovascular and therapeutics. Pharmacol Ther 122(3):216\u2013238","journal-title":"Pharmacol Ther"},{"issue":"4","key":"9822_CR29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/biores.2014.0012","volume":"3","author":"S Sart","year":"2014","unstructured":"Sart S, Teng M, Li Y (2014) Preconditioning stem cell for In vivo delivery. Biores Open Acess 3(4):137\u2013149","journal-title":"Biores Open Acess"},{"key":"9822_CR30","doi-asserted-by":"crossref","first-page":"22140","DOI":"10.1074\/jbc.M010103200","volume":"276","author":"J Han","year":"2000","unstructured":"Han J, Kim N, Kim E, Ho WE, Earm YE (2000) Modulation of ATP-sensitive potassium channels by cGMP-dependent protein kinase in rabbit ventricular myocytes. J Biol Chem 276:22140\u201322147","journal-title":"J Biol Chem"},{"key":"9822_CR31","doi-asserted-by":"crossref","first-page":"e60087","DOI":"10.1371\/journal.pone.0060087","volume":"8","author":"L Wang","year":"2013","unstructured":"Wang L, Pasha Z, Wang S, Li N, Feng Y, Lu G, Millard RW, Ashraf M (2013) Protein kinase G1 \u03b1 overexpression increases stem cell survival and cardiac function after myocardial infarction. PLoS One 8:e60087","journal-title":"PLoS One"},{"key":"9822_CR32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/164_2016_82","volume":"243","author":"GE Kim","year":"2017","unstructured":"Kim GE, Kass DA (2017) Cardiac phosphodiestrases and their modulation for treating heart disease. Handb Exp Pharmacol 243:249\u2013269","journal-title":"Handb Exp Pharmacol"},{"key":"9822_CR33","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.2174\/138161206778343118","volume":"12","author":"CT Supuran","year":"2016","unstructured":"Supuran CT, Mastrolorenzo A, Barbaro G, Scozzafava A (2016) Phosphodiestrase 5 inhibitors\u2013 drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles. Curr Pharm Des 12:3459\u20133465","journal-title":"Curr Pharm Des"},{"key":"9822_CR34","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.2174\/138161206778343046","volume":"12","author":"A Aversa","year":"2016","unstructured":"Aversa A, Bruzziches R, Pili M, Spera G (2016) Phosphodiestrase 5 inhibitors in the treatment of erectile dysfunction. Curr Pharm Des 12:3467\u20133484","journal-title":"Curr Pharm Des"},{"key":"9822_CR35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","volume":"76","author":"M Conti","year":"2007","unstructured":"Conti M, Beavo J (2007) Biochemistry and physiology of cyclic nucleotide phosphodiestrases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76:481\u2013511","journal-title":"Annu Rev Biochem"},{"key":"9822_CR36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","volume":"100","author":"K Omori","year":"2007","unstructured":"Omori K, Kotera J (2007) Overview of PDEs and their regulation. Circ Res 100:309\u2013327","journal-title":"Circ Res"},{"key":"9822_CR37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-1119(98)00303-5","volume":"216","author":"K Loughney","year":"1998","unstructured":"Loughney K, Hill TR, Florio VA, Uher L, Rosman GJ, Wolda SL, Jones BA, Howard ML, McAllister-Lucas LM, Sonnenburg WK, Francis SH, Corbin JD, Beavo JA, Ferguson K (1998) Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3\u2032,5\u2032-cyclic nucleotide phosphodiestrase. Gene 216:139\u2013147","journal-title":"Gene"},{"key":"9822_CR38","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1046\/j.1432-1327.1999.00450.x","volume":"262","author":"J Kotera","year":"1999","unstructured":"Kotera J, Fujishige K, Imai Y, Kawai E, Michibata H, Akatsuka H, Yanaka N, Omori K (1999) Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiestrases. Eur J Biochem 262:866\u2013873","journal-title":"Eur J Biochem"},{"key":"9822_CR39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.ijir.3900802","volume":"14","author":"CS Lin","year":"2002","unstructured":"Lin CS, Chow S, Lau A, Tu R, Lue TF (2002) Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters. Int J Impot Res 14:15\u201324","journal-title":"Int J Impot Res"},{"issue":"3","key":"9822_CR40","doi-asserted-by":"crossref","first-page":"e004740","DOI":"10.1161\/CIRCHEARTFAILURE.117.004740","volume":"11","author":"T Nakamura","year":"2018","unstructured":"Nakamura T, Zhu G, Ranek MJ, Kokkonen-Simon K, Zhang M, Kim GE, Tsujita K, Kass DA (2018) Prevention of PKG-1\u03b1 oxidation suppresses antihypertrophic\/antifibrotic effects from PDE5 inhibition but not sGC stimulation. Circ Heart Fail 11(3):e004740","journal-title":"Circ Heart Fail"},{"key":"9822_CR41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/emboj\/cdg051","volume":"J22","author":"SD Rybalkin","year":"2003","unstructured":"Rybalkin SD, Rybalkina IG, Shimizu-Albergine M, Tang XB, Beavo JA (2003) PDE5 is converted to an activated state upon cGMP binding to the GAF A domain. EMBO J22:469\u2013478","journal-title":"EMBO"},{"key":"9822_CR42","doi-asserted-by":"crossref","first-page":"47581","DOI":"10.1074\/jbc.M206088200","volume":"277","author":"SH Francis","year":"2002","unstructured":"Francis SH, Bessay EP, Kotera J, Grimes KA, Liu L, Thompson WJ, Corbin JD (2002) Phosphorylation of isolated human phosphodiestrase-5 regulatory domain induces an apparent conformational change and increases cGMP binding affinity. J Biol Chem 277:47581\u201347587","journal-title":"J Biol Chem"},{"key":"9822_CR43","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1046\/j.1432-1327.2000.01297.x","volume":"267","author":"JD Corbin","year":"2000","unstructured":"Corbin JD, Turko IV, Beasley A, Francis SH (2000) Phosphorylation of phosphodiestrase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur J Biochem 267:2760\u20132767","journal-title":"Eur J Biochem"},{"key":"9822_CR44","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1124\/jpet.107.126540","volume":"323","author":"MA Blount","year":"2007","unstructured":"Blount MA, Zoraghi R, Bessay EP, Beasley A, Francis SH, Corbin JD (2007) Conversion of phosphodiestrase-5 (PDE5) catalytic site to higher affinity by PDE5 inhibitors. J Pharmacol Exp Ther 323:730\u2013737","journal-title":"J Pharmacol Exp Ther"},{"key":"9822_CR45","doi-asserted-by":"crossref","first-page":"H1395","DOI":"10.1152\/ajpheart.00437.2010","volume":"299","author":"HK Haider","year":"2010","unstructured":"Haider HK, Lee YJ, Jiang S, Ahmed RP, Ryon M, Ashraf M (2010) Phosphodiestrase inhibition with tadalafil provides longer and sustained protection of stem cells. Am J Physiol Heart Circ Physiol 299:H1395\u2013H1404","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9822_CR46","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1161\/CIRCULATIONAHA.108.843979","volume":"120","author":"FN Salloum","year":"2009","unstructured":"Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, Kukreja RC (2009) Phosphodiestrase-5 inhibitor, tadalafil, protects against myocardial ischemia\/reperfusion through protein-kinase G dependent generation of hydrogen sulfide. Circulation 120:S31\u2013S36","journal-title":"Circulation"},{"key":"9822_CR47","doi-asserted-by":"crossref","first-page":"29572","DOI":"10.1074\/jbc.M801547200","volume":"283","author":"A Das","year":"2008","unstructured":"Das A, Xi L, Kukreja RC (2008) Protein kinase G-dependent cardioprotective mechanism of phosphodiestrase-5 inhibition involves phosphorylation of ERK and GSK3beta. J Biol Chem 283:29572\u201329585","journal-title":"J Biol Chem"},{"key":"9822_CR48","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0735-1097(00)00790-7","volume":"36","author":"SD Katz","year":"2000","unstructured":"Katz SD, BalidemajK HS, Wu H, Wang J, Maybaum S (2000) Acute type 5 phosphodiestrase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. J Am Coll Cardiol 36:845\u2013851","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"9822_CR49","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1136\/heart.84.2.e4","volume":"84","author":"D Abrams","year":"2000","unstructured":"Abrams D, Schulze-Neick I, Magee AG (2000) Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 84(2):E4","journal-title":"Heart"},{"key":"9822_CR50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.CIR.101.4.439","volume":"101","author":"N Sasaki","year":"2000","unstructured":"Sasaki N, Sato T, Ohler A, O\u2019Rourke B, Marb\u00e1n E (2000) Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 101:439\u2013445","journal-title":"Circulation"},{"key":"9822_CR51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4161\/cc.2.3.381","volume":"2","author":"T Matsui","year":"2003","unstructured":"Matsui T, Nagoshi T, Rosenzweig A (2003) Akt and PI3-kinase signaling in cardiomyocyte hypertrophy and survival. Cell Cycle 2:220\u2013223","journal-title":"Cell Cycle"},{"key":"9822_CR52","doi-asserted-by":"crossref","first-page":"12333","DOI":"10.1073\/pnas.172376399","volume":"99","author":"G Condorelli","year":"2002","unstructured":"Condorelli G, Drusco A, Stassi G, Bellacosa A, Roncarati R, Iaccarino G, Russo MA, Gu Y, Dalton N, Chung C, Latronico MV, Napoli C, Sadoshima J, Croce CM, Ross J Jr (2002) Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci 99:12333\u201312338","journal-title":"Proc Natl Acad Sci"},{"key":"9822_CR53","doi-asserted-by":"crossref","first-page":"22896","DOI":"10.1074\/jbc.M200347200","volume":"277","author":"T Matsui","year":"2002","unstructured":"Matsui T, Li L, Wu JC, Cook SA, Nagoshi T, Picard MH, Liao R, Rosenzweig A (2002) Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277:22896\u201322901","journal-title":"J Biol Chem"},{"key":"9822_CR54","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2005.07.047","volume":"46","author":"RM Vicari","year":"2005","unstructured":"Vicari RM, Chaitman B, Keefe D, Smith WB, Chrysant SG, Tonkon MJ, Bittar N, Weiss RJ, Morales-Ballejo H, Thadani U, Fasudil Study Group (2005) Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol 46:1803\u20131811","journal-title":"J Am Coll Cardiol"},{"key":"9822_CR55","doi-asserted-by":"crossref","first-page":"19023","DOI":"10.1074\/jbc.M213066200","volume":"278","author":"SM Ellerbroek","year":"2003","unstructured":"Ellerbroek SM, Wennerberg K, Burridge K (2003) Serine phosphorylation negatively regulates RhoA in vivo. J Biol Chem 278:19023\u201319031","journal-title":"J Biol Chem"},{"key":"9822_CR56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.CIR.0000156407.59837.C1","volume":"111","author":"GJ Gross","year":"2005","unstructured":"Gross GJ (2005) Sildenafil and endothelial dysfunction in humans. Circulation 111:721\u2013723","journal-title":"Circulation"},{"key":"9822_CR57","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.1073\/pnas.161283798","volume":"16","author":"YT Xuan","year":"2001","unstructured":"Xuan YT, Guo Y, Han H, Zhu Y, Bolli R (2001) An essential role of the JAK-STAT pathway in ischemic preconditioning. PNAS 16:9050\u20139055","journal-title":"PNAS"},{"key":"9822_CR58","doi-asserted-by":"crossref","first-page":"II","DOI":"10.1161\/01.CIR.102.10.1165","volume":"102","author":"Y Wang","year":"2000","unstructured":"Wang Y, Zhang S, Guo Y, Bao W, Wu J, Bolli R (2000) Ischemic preconditioning (PC) upregulates inducible nitric oxide synthase (iNOS), but not eNOS, in cardiac myocytes in vivo. Circulation 102:II\u201393","journal-title":"Circulation"},{"key":"9822_CR59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1570161052773933","volume":"3","author":"JC Wanstall","year":"2005","unstructured":"Wanstall JC, Homer KL, Doggrell SA (2005) Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets. Curr Vasc Pharmacol 3:41\u201353","journal-title":"Curr Vasc Pharmacol"},{"key":"9822_CR60","first-page":"116","volume":"35","author":"BM Choi","year":"2002","unstructured":"Choi BM, Pae HO, Jang SI, Kim YM, Chung HT (2002) Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J Biochem Mol Biol 35:116\u2013126","journal-title":"J Biochem Mol Biol"},{"key":"9822_CR61","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1006\/jmcc.1997.0489","volume":"29","author":"CD McWhinney","year":"1997","unstructured":"McWhinney CD, Hunt RA, Conrad KM, Dostal DE, Baker KM (1997) The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes. J Mol Cell Cardiol 29:2513\u20132524","journal-title":"J Mol Cell Cardiol"},{"key":"9822_CR62","doi-asserted-by":"crossref","first-page":"10002","DOI":"10.1074\/jbc.275.14.10002","volume":"275","author":"A Stephanou","year":"2000","unstructured":"Stephanou A, Brar BK, Scarabelli TM, Jonassen AK, Yellon DM, Marber MS, Knight RA, Latchman DS (2000) Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J Biol Chem 275:10002\u201310008","journal-title":"J Biol Chem"},{"key":"9822_CR63","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1126\/science.1164551","volume":"323","author":"J Wegrzyn","year":"2009","unstructured":"Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, Derecka M, Szczepanek K, Szelag M, Gornicka A, Moh A, Moghaddas S, Chen Q, Bobbili S, Cichy J, Dulak J, Baker DP, Wolfman A, Stuehr D, Hassan MO, Fu XY, Avadhani N, Drake JI, Fawcett P, Lesnefsky EJ, Larner AC (2009) Function of mitochondrial Stat3 in cellular respiration. Science 323:793\u2013797","journal-title":"Science"},{"key":"9822_CR64","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1161\/CIRCULATIONAHA.108.805242","volume":"118","author":"G Heusch","year":"2008","unstructured":"Heusch G, Boengler K, Schulz R (2008) Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 118:1915\u20131919","journal-title":"Circulation"},{"issue":"4","key":"9822_CR65","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.yjmcc.2011.01.002","volume":"50","author":"R Bolli","year":"2011","unstructured":"Bolli R, Stein AB, Guo Y, Wang OL, Rokosh G, Dawn B, Molkentin JD, Sanganalmath SK, Zhu Y, Xuan YT (2011) A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning. J Mol Cell Cardiol 50(4):589\u2013597","journal-title":"J Mol Cell Cardiol"},{"key":"9822_CR66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijcard.2014.12.043","volume":"182","author":"B Yu","year":"2015","unstructured":"Yu B, Kim HW, Gong M, Wang J, Millard RW, Wang Y, Ashraf M (2015) Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. Int J Cardiol 182:349\u2013360","journal-title":"Int J Cardiol"},{"key":"9822_CR67","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCRESAHA.117.305990","volume":"117","author":"M Khan","year":"2015","unstructured":"Khan M, Nickoloff E, Abramova T, Johnson J, Verma SK, Krishnamurthy P, Mackie AR, Vaughan E, Garikipati VNS, Benedict C, Ramirez V, Lambers E, Ito A, Gao E, Misener S, Luongo T, Elrod J, Qin G, Houser SR, Koch WJ, Kishore R (2015) Embryonic stem cell\u2013derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res 117:52\u201364","journal-title":"Circ Res"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09822-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-019-09822-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09822-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T22:54:09Z","timestamp":1663973649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-019-09822-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["9822"],"URL":"https:\/\/doi.org\/10.1007\/s10741-019-09822-0","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]},"assertion":[{"value":"15 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}